# UK Celiac Disease Treatment Market > UK Celiac Disease Treatment Market Research Report: Size, Share, Trend Analysis By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End Users (Hospitals and Clinics, Research Centers, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.01% - **2024:** $ 32.98 Million - **2025:** $ 36.61 Million - **2035:** $ 104 Million - **Key Players:** AbbVie (US), Gluten Free Holdings (US), General Mills (US), Kraft Heinz (US), Nestle (CH), Pinnacle Foods (US), Schär (IT), The Hain Celestial Group (US) **Report ID:** MRFR/HC/49597-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-celiac-disease-treatment-market-51354 --- ## Market Summary ## **UK Celiac Disease Treatment Market Overview** As per MRFR analysis, the UK Celiac Disease Treatment Market Size was estimated at 36.26 (USD Million) in 2023. The UK Celiac Disease Treatment Market Industry is expected to grow from 40.26(USD Million) in 2024 to 136.1 (USD Million) by 2035. The UK Celiac Disease Treatment Market CAGR (growth rate) is expected to be around 11.709% during the forecast period (2025 - 2035). **Key UK Celiac Disease Treatment Market Trends Highlighted** The UK Celiac Disease Treatment Market is experiencing notable trends driven by increasing awareness and understanding of celiac disease among the general population and healthcare professionals. The National Health Service (NHS) has been actively promoting better diagnosis and management strategies for this condition, which is encouraging more people to seek treatment options. This rise in diagnosis has sparked greater demand for gluten-free products and treatments, creating a dynamic market environment.  Opportunities in the UK market include the expansion of gluten-free food products in mainstream grocery stores and online platforms. With the growing inclination toward healthier eating habits, brands are recognizing the potential to cater to celiac patients while also appealing to a broader audience looking for gluten-free options.The release of new and gluten-free products is shifting the focus of manufacturers as they attempt to capture the attention of health-driven consumers.  There has been a recent change in the way celiac disease is approached, as it now favors personalized treatment. The technology used to manage the illness is also improving, as tools for gluten tracking and professional consultation services are now available online. Alongside these changes, there is an increase in the use of dietary and other treatment supplements, which can improve the patient experience. This trend also reflects a broader movement toward holistic health within the UK, where health products and therapies that embrace a whole-person approach are becoming increasingly popular among consumers. Overall, the UK Celiac Disease Treatment Market is poised for significant growth, driven by greater awareness, opportunities for innovation, and trends towards more personalized healthcare solutions. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** **UK Celiac Disease Treatment Market Drivers** **Increasing Awareness and Diagnosis of Celiac Disease** In the UK, the awareness and understanding of Celiac Disease have significantly improved in recent years. With the National Health Service (NHS) frequently updating guidelines for GPs and healthcare professionals, there has been a noticeable increase in the diagnosis rate of Celiac Disease. According to government health statistics, the number of diagnosed cases has risen by approximately 20% over the last five years.  This increase can be attributed to heightened awareness campaigns and better access to diagnostic tests.Health organizations, such as Coeliac UK, play a major role in educating both the public and healthcare professionals about the symptoms and implications of untreated Celiac Disease. As more individuals receive accurate diagnoses, the demand for treatments and gluten-free products within the UK Celiac Disease Treatment Market Industry is poised for significant growth. **Growth in Gluten-Free Product Offerings** The UK market has seen a substantial growth in gluten-free product offerings in recent years, which is a key driver for the UK Celiac Disease Treatment Market. A report from the Food Standards Agency indicates that the gluten-free food market has increased by over 25% since 2019, with a growing number of brands entering the market.  This increase is largely due to the rising demand from individuals with Celiac Disease and gluten intolerance. Established companies, such as Warburtons and Genius Foods, have expanded their gluten-free product lines, making it easier for consumers to find safe options.Consequently, this trend is likely to drive the sales of treatments in the UK Celiac Disease Treatment Market Industry. **Supportive Government Policies and Initiatives** The UK government has initiated several supportive policies aimed at improving the quality of life for those with Celiac Disease. For instance, the NHS has implemented policies that ensure gluten-free prescriptions are provided to diagnosed individuals. Additionally, recent reports highlight that the government has allocated increased funding for the development and distribution of gluten-free products in the healthcare system.  This funding boost is part of a broader initiative to improve the nutritional and dietary support for patients.Such actions foster a positive environment for both treatment providers and patients, stimulating growth within the UK Celiac Disease Treatment Market Industry. **Rising Incidence of Autoimmune Disorders** The incidence of autoimmune disorders, including Celiac Disease, is on the rise in the UK. According to data released by the UK Autoimmune Disease Research Network, autoimmune diseases have increased by about 10% in the last decade. This trend can be linked to various environmental factors, dietary changes, and gene-environment interactions.  The increase in the general population affected by these disorders leads to a higher demand for specialized treatments and management options for Celiac Disease.In turn, this drives growth in the UK Celiac Disease Treatment Market Industry, as healthcare providers seek to offer comprehensive solutions to an expanding patient base. **UK Celiac Disease Treatment Market Segment Insights** **Celiac Disease Treatment Market Treatment Type Insights** The UK Celiac Disease Treatment Market, particularly focused on the Treatment Type segment, showcases a diverse offering designed to meet the varying needs of individuals diagnosed with celiac disease. A principal element within this segment is the Gluten Free Diet, a fundamental and essential treatment method that is widely recognized as the cornerstone for managing celiac disease.  This dietary approach involves the complete avoidance of foods containing gluten, a protein found in wheat, barley, and rye, which can cause serious health issues for individuals with this condition. As awareness regarding gluten intolerance and celiac disease continues to grow across the UK, the prevalence of gluten-free food products is on the rise, resulting in increased availability and variety within supermarkets and health stores. Moreover, the trend towards organic and clean-label products has fostered an environment where gluten-free options are not only more accessible but also more appealing to consumers, leading to a sizable market share for this diet. Complementing the dietary approach are Vitamin and Minerals Supplements, an important support mechanism for individuals with celiac disease. Due to the malabsorption issues often faced by these patients, leading to nutrient deficiencies, these supplements play a crucial role in improving overall health and quality of life. The growing recognition of the role of nutrition in managing celiac disease symptoms has led to an increased interest in fortified supplements, driving market demand.  Health professionals often recommend such supplements to patients on gluten-free diets, ensuring they meet their nutritional requirements, further solidifying the significance of this treatment type within the UK Celiac Disease Treatment Market.Medical Therapies also represent another vital component of the Treatment Type segment. While the primary treatment for celiac disease remains a strict gluten-free diet, there is ongoing Research and Development aimed at providing additional therapeutic options for patients who struggle with dietary compliance or who experience persistent symptoms despite adhering to a gluten-free regimen.  Novel medical therapies, such as enzyme supplements and immunotherapy approaches, are in various stages of development and clinical trials. These innovations demonstrate the commitment within the healthcare industry to address the complexities associated with celiac disease, providing hope for enhanced management options in the future. Overall, the Treatment Type segment within the UK Celiac Disease Treatment Market reflects a multifaceted approach that addresses the distinct needs of individuals diagnosed with this lifelong condition. Each treatment method, from dietary changes to the use of supplements and potential medical therapies, plays a significant role in managing and alleviating the symptoms of celiac disease.  The growing understanding and recognition of these various treatment options underscore the commitment to enhancing the quality of life for those affected by celiac disease in the UK, encouraging continuous development and improvement in patient care. The market growth is supported by rising awareness of celiac disease in the healthcare community and increasing consumer demand for products that cater to those diagnosed, thereby creating ample opportunities for future advancements in the industry. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** **Celiac Disease Treatment Market End User Insights** The UK Celiac Disease Treatment Market showcases a diverse range of End Users, with significant contributions from Hospitals and Clinics, Research Centers, and other platforms. Hospitals and Clinics play a pivotal role as primary healthcare providers, offering diagnostic services and treatment plans that adhere to clinical guidelines. Their significance is underlined by the growing prevalence of celiac disease in the UK, which necessitates immediate medical attention and management.  Research Centers further enhance the market dynamics by focusing on innovative treatments and therapies, contributing to enhanced patient care and understanding of the disease.This segment fosters advancements in Research and Development, leading to improved diagnostic tools and therapeutic options. Additionally, other players in the segment, such as dietary services and health education platforms, bridge the gap between medical treatment and lifestyle adjustments, promoting better health outcomes.  The growing awareness and recognition of celiac disease in the UK, coupled with emerging treatment methodologies, create a robust landscape for the End User segment, ultimately driving market growth and improving patient quality of life.Overall, the segmentation reflects a comprehensive approach to addressing the needs of celiac disease patients, aligning with trends towards personalized medicine and patient-centered care in the healthcare industry. **UK Celiac Disease Treatment Market Key Players and Competitive Insights** The UK Celiac Disease Treatment Market has witnessed significant growth in recent years, driven by an increasing awareness of celiac disease among the population and a rising demand for gluten-free products. As more individuals are diagnosed with this autoimmune disorder, the market has seen an inflow of various players offering gluten-free alternatives and specialty treatments aimed at improving the quality of life for those affected.  The competitive landscape is defined by the collaboration of pharmaceutical companies, nutritional brands, and food manufacturers, all focused on developing innovative solutions that cater specifically to the needs of celiac patients. Companies operate in a challenging environment where regulatory standards and consumer preferences rapidly evolve, making adaptability and market intelligence crucial for success. Schär is a prominent player in the UK Celiac Disease Treatment Market, known for its extensive range of gluten-free products that cater specifically to those managing celiac disease. The company's strengths lie in its robust product portfolio, which includes everything from baked goods to pasta alternatives, providing consumers with versatile options to meet their dietary needs. Schär's established presence in the UK market is bolstered by its commitment to research and development, ensuring that its offerings not only meet state-of-the-art gluten-free standards but are also appealing to a broader audience, including those without dietary restrictions.  The brand has successfully positioned itself as a go-to choice for celiac patients, cultivating a loyal customer base through consistent quality and targeted marketing strategies.Free2b operates within the UK Celiac Disease Treatment Market as a brand dedicated to providing safe, nutritious options for those requiring gluten-free foods. The company's key offerings include a range of snacks and meal solutions designed for individuals managing celiac disease. Free2b prides itself on utilizing high-quality ingredients and ensuring that all products are free from gluten and other allergens, thereby enhancing its appeal in the competitive landscape.  The brand's market presence has been further reinforced through strategic partnerships and collaborations aimed at expanding its distribution channels within the UK. By focusing on consumer needs and preferences, Free2b has carved out a niche in the market that underscores its strengths in innovation and customer engagement. The company has also explored potential mergers and acquisitions to broaden its reach and enhance its product offerings, positioning itself as a relevant player in the constantly evolving gluten-free sector. **Key Companies in the UK Celiac Disease Treatment Market Include:** **UK Celiac Disease Treatment Market Industry Developments** In recent developments within the UK Celiac Disease Treatment Market, companies like Schär and Genius Gluten Free have continued to innovate their product lines, enhancing availability for consumers with gluten sensitivity. The introduction of new gluten-free options from brands such as Alpro and Doves Farm has broadened the market landscape, catering to the increasing demand for better dietary choices.  Notably, in August 2023, Schar UK Ltd announced a partnership with local supermarkets to improve product access, while Free2b unveiled new snack lines targeting health-conscious consumers. The market's valuation has benefited from a growing awareness of celiac disease, with a reported increase in sales across gluten-free products by over 15% in 2022. In terms of mergers and acquisitions, no major developments have been reported for Schär, Free2b, or other relevant companies in the last few months.  However, pre-2022, several collaborations were noted, emphasizing a trend towards consolidation and sharing of resources within the industry. This environment indicates a robust growth trajectory for the UK market, fostering increased investment and development, while the introduction of Natasha's Law is expected to further enhance consumer confidence in gluten-free labeling and safety. **UK Celiac Disease Treatment Market Segmentation Insights** **Celiac Disease Treatment Market Treatment Type Outlook** **Celiac Disease Treatment Market End User Outlook** - Hospitals and Clinics - Research Centers ## Market Drivers ### Expansion of Gluten-Free Food Options The expansion of gluten-free food options in the UK is a significant driver for the celiac disease-treatment market. As consumer demand for gluten-free products continues to rise, food manufacturers are increasingly introducing a variety of gluten-free alternatives. This trend not only caters to individuals with celiac disease but also appeals to those with gluten sensitivities and health-conscious consumers. The gluten-free food market in the UK has been projected to grow at a CAGR of around 10% over the next few years. This proliferation of gluten-free products enhances the quality of life for patients and encourages adherence to dietary restrictions, thereby supporting the overall treatment landscape within the celiac disease-treatment market. ### Increasing Awareness of Celiac Disease The rising awareness of celiac disease among the UK population is a crucial driver for the celiac disease-treatment market. Educational campaigns and initiatives by health organizations have led to a better understanding of the disease, its symptoms, and the importance of diagnosis. As more individuals recognize the signs of celiac disease, the demand for testing and subsequent treatment options is likely to increase. This heightened awareness may lead to a surge in the number of diagnosed cases, which, according to recent estimates, could reach approximately 1 in 100 individuals in the UK. Consequently, The celiac disease treatment market is expected to expand as healthcare providers respond to the growing need for effective treatment options. ### Advancements in Diagnostic Technologies Technological advancements in diagnostic methods are significantly impacting the celiac disease-treatment market. Improved testing techniques, such as genetic testing and serological assays, have enhanced the accuracy and speed of celiac disease diagnosis. These innovations not only facilitate earlier detection but also encourage more individuals to seek medical advice, thereby increasing the patient population requiring treatment. The UK healthcare system has seen a shift towards more precise diagnostic tools, which may lead to an increase in the number of patients diagnosed with celiac disease. As a result, the celiac disease-treatment market is poised for growth, driven by the need for effective therapeutic options for a larger patient base. ### Government Support and Policy Initiatives Government support and policy initiatives play a pivotal role in shaping the celiac disease-treatment market. The UK government has implemented various policies aimed at improving healthcare access and affordability for individuals with celiac disease. These initiatives may include funding for research, subsidies for gluten-free products, and public health campaigns to promote awareness. Such support not only aids in the diagnosis and treatment of celiac disease but also fosters a more inclusive environment for patients. As a result, the celiac disease-treatment market is likely to benefit from increased funding and resources, which could enhance treatment options and improve patient outcomes. ### Growing Research and Development Activities The growing emphasis on research and development activities within the celiac disease-treatment market is a notable driver. Pharmaceutical companies and research institutions in the UK are increasingly investing in the development of novel therapies and treatment modalities for celiac disease. This focus on R&D is driven by the need for more effective treatments beyond the current gluten-free diet, which remains the primary management strategy. Clinical trials and studies exploring new therapeutic agents are underway, potentially leading to breakthroughs in treatment options. As these innovations emerge, they may significantly impact the celiac disease-treatment market, offering patients more choices and improving overall disease management. ## Future Outlook The [Celiac Disease Treatment Market](https://www.marketresearchfuture.com/reports/celiac-disease-treatment-market-8474) is projected to grow at 11.01% CAGR from 2025 to 2035, driven by increasing awareness, innovative therapies, and rising diagnosis rates. **New opportunities:** - Development of personalized gluten-free meal plans for patients - Expansion of telehealth services for remote patient monitoring - Investment in research for novel therapeutic agents targeting celiac disease By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Treatment Type: Gluten Free Diet (Largest) vs. Medical Therapies (Fastest-Growing) In the UK celiac disease-treatment market, the Gluten Free Diet dominates the treatment landscape, holding a significant share of the market. This dietary approach is widely recognized as fundamental among patients diagnosed with celiac disease, offering essential relief from symptoms and promoting overall health. In contrast, Vitamin and Minerals Supplements are also important, supporting the dietary needs of patients, but they do not hold as large a share as gluten-free diets. However, the fastest growth is currently observed in Medical Therapies. This evolving segment includes innovative treatments that are increasingly being explored to complement dietary restrictions. Drivers for this growth include rising patient awareness, ongoing research advancements, and an increasing prevalence of celiac disease, which collectively fuel demand for more versatile and effective treatment options. Vitamin and Minerals Supplements (Dominant) vs. Medical Therapies (Emerging) Vitamin and Minerals Supplements serve as a dominant support mechanism for individuals dealing with celiac disease, addressing nutritional deficits that stem from gluten-induced damage to the intestines. These supplements are critical for enhancing the overall well-being of patients, leading to better health outcomes. In contrast, Medical Therapies represent an emerging trend in the treatment landscape. This segment is gaining traction as new formulations and therapies are developed to provide alternatives or adjuncts to dietary management. The increasing focus on personalized medicine and innovative therapeutic solutions positions Medical Therapies as a compelling option for patients seeking comprehensive treatment strategies. ### By End User: Hospitals and Clinics (Largest) vs. Research Centers (Fastest-Growing) In the UK celiac disease-treatment market, Hospitals and Clinics dominate the end user segment, capturing a significant market share due to their essential role in patient diagnosis and treatment. These facilities benefit from a steady influx of patients seeking treatment, ensuring their continued prominence in the market. In contrast, Research Centers are emerging rapidly, driven by innovative research and development efforts aimed at improving treatment methods and understanding the disease better. The growth trends within this segment are largely propelled by advancements in medical technology and increased awareness about celiac disease. Hospitals and Clinics are enhancing their service offerings, while Research Centers are focusing on groundbreaking trials and collaborations with pharmaceutical companies. This synergy between treatment and research is crucial for driving forward solutions that address patients' needs more effectively, making Research Centers a pivotal player in the evolving landscape. Hospitals and Clinics (Dominant) vs. Research Centers (Emerging) Hospitals and Clinics serve as the backbone of the treatment landscape for celiac disease, offering comprehensive services that include diagnosis, dietary management, and ongoing patient support. Their established infrastructure and staff expertise provide them with a substantial market advantage, ensuring they remain the first point of contact for most patients. On the other hand, Research Centers are classified as emerging players, focusing on innovation and development of new therapies and treatment modalities. Their interconnectedness with academia and pharmaceutical research allows them to remain at the forefront of scientific advancements. As these centers drive forward crucial research initiatives, their role in shaping the future of celiac disease treatments is becoming increasingly vital. ## Competitive Benchmarking The celiac disease-treatment market in the UK is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as AbbVie (US), Schär (IT), and Nestlé (CH) are actively pursuing strategies that emphasize product development and market expansion. AbbVie (US) has focused on enhancing its portfolio through research and development, particularly in biologics that target celiac disease symptoms. Schär (IT), a leader in gluten-free products, has positioned itself as a go-to brand for consumers seeking dietary solutions, while Nestlé (CH) has been investing in digital transformation to better engage with health-conscious consumers. Collectively, these strategies indicate a market that is not only competitive but also responsive to evolving consumer needs and regulatory landscapes.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This dynamic fosters a competitive environment where innovation and consumer engagement are paramount, as smaller firms often rely on partnerships with larger entities to scale their operations. In October AbbVie (US) announced a collaboration with a leading UK research institution to develop a novel therapeutic approach for celiac disease, focusing on personalized medicine. This strategic move underscores AbbVie’s commitment to innovation and positions the company to potentially lead in the development of targeted treatments that could significantly improve patient outcomes. The collaboration is expected to leverage cutting-edge research to expedite the drug development process, thereby enhancing AbbVie’s competitive edge in the market. In September Schär (IT) launched a new line of gluten-free products specifically designed for children, aiming to capture a niche market segment that has been underserved. This initiative not only broadens Schär’s product portfolio but also aligns with the growing trend of health-conscious parenting. By addressing the dietary needs of children with celiac disease, Schär is likely to strengthen its brand loyalty and expand its consumer base, which could lead to increased market share in the UK. In August Nestlé (CH) unveiled a digital platform aimed at educating consumers about celiac disease and gluten-free living. This initiative reflects Nestlé’s strategic focus on digital engagement and consumer education, which are essential in fostering brand trust and loyalty. By providing valuable resources and information, Nestlé positions itself as a thought leader in the gluten-free space, potentially influencing purchasing decisions and enhancing customer retention. As of November the competitive trends in the celiac disease-treatment market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. This shift suggests that companies that prioritize these areas will likely emerge as leaders in the celiac disease-treatment market. ## Recent News & Developments In recent developments within the UK Celiac Disease Treatment Market, companies like Schär and Genius Gluten Free have continued to innovate their product lines, enhancing availability for consumers with gluten sensitivity. The introduction of new gluten-free options from brands such as Alpro and Doves Farm has broadened the market landscape, catering to the increasing demand for better dietary choices.  Notably, in August 2023, Schar UK Ltd announced a partnership with local supermarkets to improve product access, while Free2b unveiled new snack lines targeting health-conscious consumers. The market's valuation has benefited from a growing awareness of celiac disease, with a reported increase in sales across gluten-free products by over 15% in 2022. In terms of mergers and acquisitions, no major developments have been reported for Schär, Free2b, or other relevant companies in the last few months.  However, pre-2022, several collaborations were noted, emphasizing a trend towards consolidation and sharing of resources within the industry. This environment indicates a robust growth trajectory for the UK market, fostering increased investment and development, while the introduction of Natasha's Law is expected to further enhance consumer confidence in gluten-free labeling and safety. ## Report Scope | MARKET SIZE 2024 | 32.98(USD Million) | | --- | --- | | MARKET SIZE 2025 | 36.61(USD Million) | | MARKET SIZE 2035 | 104.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.01% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | AbbVie (US), Gluten Free Holdings (US), General Mills (US), Kraft Heinz (US), Nestle (CH), Pinnacle Foods (US), Schär (IT), The Hain Celestial Group (US) | | Segments Covered | Treatment Type, End User | | Key Market Opportunities | Emerging gluten-free innovations and personalized therapies enhance growth potential in the celiac disease-treatment market. | | Key Market Dynamics | Rising demand for gluten-free products drives innovation in celiac disease treatment options and regulatory adaptations. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What was the market valuation for the UK celiac disease-treatment market in 2024?** A: The market valuation for the UK celiac disease-treatment market was $32.98 Million in 2024. **Q: What is the projected market valuation for the UK celiac disease-treatment market by 2035?** A: The projected market valuation for the UK celiac disease-treatment market is $104.0 Million by 2035. **Q: What is the expected CAGR for the UK celiac disease-treatment market during the forecast period 2025 - 2035?** A: The expected CAGR for the UK celiac disease-treatment market during the forecast period 2025 - 2035 is 11.01%. **Q: Which treatment type segment had the highest valuation in 2024?** A: In 2024, the Gluten Free Diet segment had the highest valuation at $48.0 Million. **Q: What are the key players in the UK celiac disease-treatment market?** A: Key players in the UK celiac disease-treatment market include AbbVie, Gluten Free Holdings, General Mills, Kraft Heinz, Nestle, Pinnacle Foods, Schär, and The Hain Celestial Group. **Q: What was the valuation of Vitamin and Minerals Supplements in 2024?** A: The valuation of Vitamin and Minerals Supplements in 2024 was $32.0 Million. **Q: How much did the Medical Therapies segment contribute to the market in 2024?** A: The Medical Therapies segment contributed $24.0 Million to the market in 2024. **Q: Which end user segment had the highest valuation in 2024?** A: The Hospitals and Clinics end user segment had the highest valuation at $38.0 Million in 2024. **Q: What is the projected growth for the Research Centers segment by 2035?** A: The Research Centers segment is projected to grow to $30.0 Million by 2035. **Q: What is the valuation of the Others end user segment in 2024?** A: The Others end user segment had a valuation of $36.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-celiac-disease-treatment-market-51354*